-+ 0.00%
-+ 0.00%
-+ 0.00%

Canaccord Genuity Maintains Buy on Guardant Health, Raises Price Target to $205

Benzinga·07/14/2026 11:55:33
Listen to the news
Canaccord Genuity analyst Kyle Mikson maintains Guardant Health (NASDAQ:GH) with a Buy and raises the price target from $135 to $205.